# Crosslight Partners

> Crosslight Partners is a VC fund backing Biotechnology, Medical and Life Science. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Nov 2021
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/crosslight-partners/
- Website: https://www.crosslightpartners.com/

Crosslight Partners is a growth equity firm. The firm invests in the environment, healthcare, impact, and technology sectors across Europe.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Life Science | 1 | 50% |
| Energy Storage | 1 | 50% |
| Medical Device | 1 | 50% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Sweden | 1 | 50% |
| Estonia | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Gelatex Technologies | Gelatex is a Techstars-backed materials technology company that invented the fastest technology for producing bio-based nanofibers on a large scale. It is a platform technology that enables faster and up to 100 cheaper nanofiber production for applications like 3D scaffolds for tissue engineering, cultured meat, bio-based filters, eco-friendlyleather-like textile, energy storage, wound care, and many more. The technology is patent-pending and the machinery fully functional. The company was founded in 2016 and until COVID-19 pandemic developed eco-friendly leather-like textile from gelatin nanofibers, using this nanofiber production technology as part of the process. COVID-19 was a trigger to understand the wider potential of the technology which then led to pivot.The company is based in Estonia and holding incorporated in UK (2019). | $1.2M | Seed | Nov 25, 2021 |  |
| Sigrid Therapeutics | Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics. | $8.4M | Venture - Series Unknown | Nov 10, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Change Ventures](https://shizune.co/investors/profile/change-ventures) — VC Fund, 1 deal together
- [Hans and Barbara Bergström](https://shizune.co/investors/profile/hans-and-barbara-bergstr%C3%B6m) — VC Fund, 1 deal together
- [Irrus Investments](https://shizune.co/investors/profile/irrus-investments) — VC Fund, 1 deal together
- [Joyance Partners](https://shizune.co/investors/profile/joyance-partners) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Specialist VC](https://shizune.co/investors/profile/united-angels-vc) — VC Fund
- [Superangel](https://shizune.co/investors/profile/superangel) — VC Fund
- [Tera Ventures](https://shizune.co/investors/profile/tera-ventures) — VC Fund

## Featured in investor lists
- [Food and Beverage Investors in Estonia](https://shizune.co/investors/food-and-beverage-investors-estonia)
- [Food and Beverage VC Funds in Estonia](https://shizune.co/investors/food-and-beverage-vc-funds-estonia)
- [Medical Investors in Estonia](https://shizune.co/investors/medical-investors-estonia)
- [Medical Device Investors in Sweden](https://shizune.co/investors/medical-device-investors-sweden)
- [Medical Device VC Funds in Sweden](https://shizune.co/investors/medical-device-vc-funds-sweden)
- [Manufacturing Investors in Estonia](https://shizune.co/investors/manufacturing-investors-estonia)

## FAQ

### What does Crosslight Partners invest in?

Crosslight Partners invests primarily in Biotechnology, Medical and Life Science startups, most often at Seed and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Crosslight Partners last invest?

The most recent investment recorded for Crosslight Partners closed in Nov 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co